Long-term efficacy of immunization against hepatitis B virus in infants at high-risk analyzed by polymerase chain reaction.

[1]  K. Koike,et al.  Persistent viremia after recovery from self‐limited acute hepatitis B , 1998, Hepatology.

[2]  A. Lok,et al.  Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis , 1998, Hepatology.

[3]  L. Mimms,et al.  The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia , 1997, Hepatology.

[4]  S. Shirahama,et al.  Efficacy of immunization of high‐risk infants against hepatitis B virus evaluated by polymerase chain reaction , 1997, Journal of medical virology.

[5]  C. Teo,et al.  Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales. , 1997, The Journal of infectious diseases.

[6]  Luan-Yin Chang,et al.  Detection of hepatitis B surface gene mutation in carrier children with or without immunoprophylaxis at birth. , 1997, The Journal of infectious diseases.

[7]  K. Hasegawa,et al.  A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B. , 1996, Hepatology.

[8]  H. Whittle,et al.  Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages , 1995, The Lancet.

[9]  H. Thomas,et al.  A unique insertion in the S gene of surface antigen–negative hepatitis B virus Chinese carriers , 1995, Hepatology.

[10]  H. Margolis,et al.  Long-Term Efficacy Of Active Postexposure Immunization Of Infants For Prevention Of Hepatitis B Virus Infection , 1995 .

[11]  Z. Ye,et al.  Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. , 1995, Vaccine.

[12]  S. Marion,et al.  Long-term follow-up of hepatitis B vaccine in infants of carrier mothers. , 1994, American journal of epidemiology.

[13]  A. Zuckerman,et al.  Protective efficacy of hepatitis B vaccines in neonates , 1994, Journal of medical virology.

[14]  F. Chisari,et al.  Hepatitis B virus persistence after recovery from acute viral hepatitis. , 1994, The Journal of clinical investigation.

[15]  A. Mason,et al.  Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen. , 1992, Gastroenterology.

[16]  Y. Poovorawan,et al.  Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers. , 1992, The Pediatric infectious disease journal.

[17]  H. Miyazaki,et al.  Mutations within the S Gene of Hepatitis B Virus Transmitted from Mothers to Babies Immunized with Hepatitis B Immune Globulin and Vaccine , 1992, Pediatric Research.

[18]  V. Suvatte,et al.  Long term efficacy of hepatitis B immunoprophylaxis in neonates at risk: using different vaccine and schedule. , 1992, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[19]  H. Tajiri,et al.  Mass Protection Program of Perinatal Hepatitis B Virus Infection in Japan and Impact of an Optional Booster Vaccination on Its Efficacy , 1991, Acta paediatrica Japonica : Overseas edition.

[20]  A. Zuckerman,et al.  Vaccine-induced escape mutant of hepatitis B virus , 1990, The Lancet.

[21]  G. Calandra,et al.  Vaccination of infants and children against hepatitis B. , 1990, Pediatric clinics of North America.

[22]  H. Inskip,et al.  The pattern of childhood hepatitis B infection in two Gambian villages. , 1990, The Journal of infectious diseases.

[23]  S. Nagataki,et al.  Changes in HBsAg carrier rate in Goto Islands, Nagasaki Prefecture, Japan , 1990, The Lancet.

[24]  S. Hadler,et al.  Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization. , 1989, Reviews of infectious diseases.

[25]  F. Deinhardt,et al.  Detection of hepatitis B virus in serum using amplification of viral DNA by means of the polymerase chain reaction , 1989, Journal of medical virology.

[26]  K. Shiraki,et al.  National Project on the Prevention of Mother‐to‐Infant Infection by Hepatitis B Virus in Japan , 1988, Acta paediatrica Japonica : Overseas edition.

[27]  R. Purcell,et al.  Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[28]  H. Margolis,et al.  Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial. , 1985, Pediatrics.

[29]  H. Whittle,et al.  HEPATITIS B VIRUS INFECTION IN TWO GAMBIAN VILLAGES , 1983, The Lancet.

[30]  F. Hsieh,et al.  HEPATITIS B IMMUNE GLOBULIN (HBIG) EFFICACY IN THE INTERRUPTION OF PERINATAL TRANSMISSION OF HEPATITIS B VIRUS CARRIER STATE Initial Report of a Randomised Double-Blind Placebo-Controlled Trial , 1981, The Lancet.

[31]  W. Szmuness,et al.  HBeAg and anti‐hbe detection by radioimmunoassay: Correlation with vertical transmission of hepatitis B virus in Taiwan , 1979, Journal of medical virology.

[32]  R. Beasley,et al.  Vertical transmission of hepatitis B antigen in Taiwan. , 1975, The New England journal of medicine.